|
|
Article: ALK-Abello: New Tablet-Based Immunotherapy for Grass Allergy Approved.
- Article from:
- PR Newswire Europe
- Article date:
- March 16, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HEyRSHOLM, Denmark, March 16 /PRNewswire/ --
- The Swedish Medical Products Agency has Approved ALK-Abello's Tablet-Based Immunotherapy, GRAZAX(R), for the Treatment of Grass Pollen Allergy. ALK-Abello will now Submit Applications for GRAZAX(R) in Other European Countries Using the Mutual Recognition Procedure
ALK-Abello's tablet-based immunotherapy, GRAZAX(R), has been approved by the Swedish Medical Products Agency for the treatment of grass pollen allergy.
ALK-Abello will now submit further applications in other European countries via the Mutual Recognition Procedure. ALK-Abello still expects GRAZAX(R) to be launched in the first European ...